Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach | Zendy

Katsunori Iijima | Zendy; Yasuhiko Abe | Zendy; Ryosuke Kikuchi | Zendy; Tomoyuki Koike | Zendy; Shuichi Ohara | Zendy; P. Sipponen | Zendy; Tooru Shimosegawa | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach

Author(s) -

Katsunori Iijima,

Yasuhiko Abe,

Ryosuke Kikuchi,

Tomoyuki Koike,

Shuichi Ohara,

P. Sipponen,

Tooru Shimosegawa

Publication year - 2009

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.15.853

Subject(s) - atrophic gastritis , gastroenterology , medicine , biomarker , gastritis , helicobacter pylori , stomach , gastric mucosa , antrum , biopsy , atrophy , rapid urease test , pathology , biology , biochemistry

To study the value of serum biomarker tests to differentiate between patients with healthy or diseased stomach mucosa: i.e. those with Helicobacter pylori (H pylori) gastritis or atrophic gastritis, who have a high risk of gastric cancer or peptic ulcer diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research